FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4680011000001101: Cytarabine 100mg/5ml solution for injection vials (Mayne Pharma Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18157701000001111 Cytarabine 100mg/5ml solution for injection vials (Mayne Pharma Plc) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
107386801000001117 Cytarabine 100mg/5ml solution for injection vials (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cytarabine 100mg/5ml solution for injection vials (Mayne Pharma Plc) Is a Cytarabine 100mg/5ml solution for injection vials true Inferred relationship Existential restriction modifier
Cytarabine 100mg/5ml solution for injection vials (Mayne Pharma Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cytarabine 100mg/5ml solution for injection vials (Mayne Pharma Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Cytarabine 100mg/5ml solution for injection vials (Mayne Pharma Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cytarabine 100mg/5ml solution for injection vials (Mayne Pharma Plc) Has active ingredient Cytarabine true Inferred relationship Existential restriction modifier
Cytarabine 100mg/5ml solution for injection vials (Mayne Pharma Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cytarabine 100mg/5ml solution for injection vials (Mayne Pharma Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cytarabine 100mg/5ml solution for injection vials (Mayne Pharma Plc) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Cytarabine 100mg/5ml solution for injection vials (Mayne Pharma Plc) Has specific active ingredient Cytarabine true Inferred relationship Existential restriction modifier
Cytarabine 100mg/5ml solution for injection vials (Mayne Pharma Plc) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Cytarabine 100mg/5ml solution for injection vials (Mayne Pharma Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Cytarabine 100mg/5ml solution for injection vials (Mayne Pharma Plc) Has manufactured dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cytarabine 100mg/5ml solution for injection vials (Mayne Pharma Plc) 5 vial 5 x 5ml vials Is pack of False Cytarabine 100mg/5ml solution for injection vials (Mayne Pharma Plc) Inferred relationship Existential restriction modifier
Cytarabine 100mg/5ml solution for injection vials (Mayne Pharma Plc) 5 vial 5 x 5ml vials Has AMP True Cytarabine 100mg/5ml solution for injection vials (Mayne Pharma Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start